TrialAnti-cancer drugs2019

Interferon-α versus interleukin-2 in Chinese patients with malignant melanoma: a randomized, controlled, trial.

Shenglong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.